STOCK TITAN

Aflac Incorporated Announces Increase in Shares Authorized for Repurchase

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Aflac (NYSE: AFL) has announced a significant expansion of its share repurchase program. The company's Board of Directors has authorized the purchase of 100 million additional shares of common stock. This new authorization complements the existing 30.9 million shares remaining from the November 2022 authorization, bringing the total available for repurchase to approximately 130.9 million shares.

The company plans to execute these repurchases through open market or negotiated transactions, with timing dependent on market conditions.

Aflac (NYSE: AFL) ha annunciato un'importante estensione del suo programma di riacquisto di azioni. Il Consiglio di Amministrazione ha autorizzato l'acquisto di 100 milioni di azioni aggiuntive ordinarie. Questa nuova autorizzazione si aggiunge alle 30,9 milioni di azioni ancora disponibili dall'autorizzazione di novembre 2022, portando il totale disponibile per il riacquisto a circa 130,9 milioni di azioni.

L'azienda prevede di eseguire questi riacquisti tramite operazioni sul mercato aperto o negoziate, con i tempi che dipenderanno dalle condizioni di mercato.

Aflac (NYSE: AFL) ha anunciado una importante ampliación de su programa de recompra de acciones. El Consejo de Administración ha autorizado la compra de 100 millones de acciones adicionales ordinarias. Esta nueva autorización se suma a las 30,9 millones de acciones que aún quedan de la autorización de noviembre de 2022, elevando el total disponible para recompra a aproximadamente 130,9 millones de acciones.

La compañía tiene previsto ejecutar estas recompras mediante transacciones en el mercado abierto o negociadas, y el calendario dependerá de las condiciones del mercado.

Aflac (NYSE: AFL)가 자사 주식 환매 프로그램을 대폭 확대한다고 발표했습니다. 이사회는 보통주 1억 주 추가 매입을 승인했습니다. 이번 승인으로 2022년 11월 승인분 중 남아 있던 3090만 주와 합쳐 환매 가능 규모가 약 1억3090만 주로 늘어났습니다.

회사는 이러한 환매를 시장에서의 공개 매매 또는 협상 거래를 통해 수행할 계획이며, 집행 시점은 시장 상황에 따라 달라집니다.

Aflac (NYSE: AFL) a annoncé une extension significative de son programme de rachat d'actions. Le conseil d'administration a autorisé l'achat de 100 millions d'actions supplémentaires ordinaires. Cette nouvelle autorisation s'ajoute aux 30,9 millions d'actions restant de l'autorisation de novembre 2022, portant le total disponible pour rachat à environ 130,9 millions d'actions.

La société prévoit d'exécuter ces rachats par des transactions sur le marché ouvert ou négociées, le calendrier dépendant des conditions du marché.

Aflac (NYSE: AFL) hat eine erhebliche Ausweitung seines Aktienrückkaufprogramms angekündigt. Der Vorstand hat den Erwerb von 100 Millionen zusätzlichen Aktien des Stammkapitals genehmigt. Diese neue Genehmigung ergänzt die verbleibenden 30,9 Millionen Aktien aus der Autorisierung vom November 2022 und erhöht die insgesamt zum Rückkauf verfügbare Menge auf etwa 130,9 Millionen Aktien.

Das Unternehmen plant, diese Rückkäufe über offene Markttransaktionen oder verhandelte Geschäfte durchzuführen; der Zeitpunkt richtet sich nach den Marktbedingungen.

Positive
  • Board authorized purchase of 100 million additional shares
  • Total shares available for repurchase increased to 130.9 million
  • Demonstrates strong commitment to returning value to shareholders
Negative
  • None.

COLUMBUS, Ga., Aug. 12, 2025 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today announced that its Board of Directors has authorized the purchase of up to 100 million shares of its common stock. This authorization is in addition to the 30.9 million shares as of June 30, 2025, that remained under the November 8, 2022 authorization, bringing the total number of shares available for purchase to approximately 130.9 million. The company anticipates that the repurchase of shares will be conducted from time to time in open market or negotiated transactions, depending on market conditions.

ABOUT AFLAC INCORPORATED

Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for nearly seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.1 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force. The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 19 consecutive years (2025) and Fortune's World's Most Admired Companies for 24 years (2025). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021 and has been included in the Dow Jones Sustainability North America Index (2024) for 11 years. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/español. Investors may learn more about Aflac Incorporated and its commitment to corporate social responsibility and sustainability at investors.aflac.com under "Sustainability."

1 LIMRA 2024 U.S. Supplemental Health Insurance Total Market Report

FORWARD-LOOKING INFORMATION 

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. Aflac Incorporated (the Parent Company) and its subsidiaries (collectively with the Parent Company, the Company) desire to take advantage of these provisions. This document contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by Company officials in communications with the financial community and contained in documents filed with the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as "expect," "anticipate," "believe," "goal," "objective," "may," "should," "estimate," "intends," "projects," "will," "assumes," "potential," "target," "outlook" or similar words as well as specific projections of future results, generally qualify as forward-looking. The Company undertakes no obligation to update such forward-looking statements.

The Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements: 

  • difficult conditions in global capital markets and the economy, including inflation
  • defaults and credit downgrades of investments
  • global fluctuations in interest rates and exposure to significant interest rate risk
  • concentration of business in Japan
  • limited availability of acceptable yen-denominated investments
  • foreign currency fluctuations in the yen/dollar exchange rate
  • differing interpretations applied to investment valuations
  • significant valuation judgments in determination of expected credit losses recorded on the Company's investments
  • decreases in the Company's financial strength or debt ratings
  • decline in creditworthiness of other financial institutions
  • the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners
  • deviations in actual experience from pricing and reserving assumptions
  • ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives
  • interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality, integrity or privacy of sensitive data residing on such systems, and uncertainty regarding the impact of the incident involving unauthorized access to the Company's network in June 2025
  • subsidiaries' ability to pay dividends to the Parent Company
  • inherent limitations to risk management policies and procedures
  • operational risks of third-party vendors
  • tax rates applicable to the Company may change
  • failure to comply with restrictions on policyholder privacy and information security
  • extensive regulation and changes in law or regulation by governmental authorities
  • competitive environment and ability to anticipate and respond to market trends
  • catastrophic events, including, but not limited to, as a result of climate change, epidemics, pandemics, tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, major public health issues, terrorism or other acts of violence, and damage incidental to such events
  • ability to protect the Aflac brand and the Company's reputation
  • ability to effectively manage key executive succession
  • changes in accounting standards
  • level and outcome of litigation or regulatory inquiries
  • allegations or determinations of worker misclassification in the United States

(PRNewsfoto/Aflac Incorporated)

Analyst and investor contact - David A. Young, 706.596.3264 or 800.235.2667 or dyoung@aflac.com

Media contact – Ines Gutzmer, 762.207.7601 or igutzmer@aflac.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/aflac-incorporated-announces-increase-in-shares-authorized-for-repurchase-302528231.html

SOURCE Aflac Incorporated

FAQ

How many new shares did Aflac's Board authorize for repurchase in August 2025?

Aflac's Board of Directors authorized the purchase of 100 million additional shares of its common stock.

What is the total number of shares available for repurchase under Aflac's buyback program?

After the new authorization, Aflac has approximately 130.9 million shares available for repurchase, combining the new 100 million shares with 30.9 million remaining from the November 2022 authorization.

How will Aflac execute its share repurchase program?

Aflac plans to conduct the share repurchases through open market or negotiated transactions, with timing based on market conditions.

How many shares remained available from Aflac's November 2022 share repurchase authorization?

As of June 30, 2025, 30.9 million shares remained available from Aflac's November 8, 2022 share repurchase authorization.
Aflac Inc

NYSE:AFL

AFL Rankings

AFL Latest News

AFL Latest SEC Filings

AFL Stock Data

55.37B
478.14M
10.43%
59.86%
1.51%
Insurance - Life
Accident & Health Insurance
Link
United States
COLUMBUS